图书简介

Section 1: Emerging and Established Technologies; 1. Genetic Methodologies and Applications; Shaun M. Purcell; 2. Network Methods for Elucidating the Complexity of Common Human Diseases; Eric E. Schadt; 3. The Human Brain and its Epigenome; Andrew Chess and Schahram Akbarian; 4. Methods for In Vivo Gene Manipulation; Lisa M. Monteggia and Wei Xu; 5. Application of Stem Cells to Understanding Psychiatric Disorders; Zijia Zhang and Kristen Brennand; 6. Optogenetics and Related Technologies for Psychiatric Disease Research: Current Status and Challenges; Lief E. Fenno and Karl Deisseroth; 7. In Vivo Circuit Analysis; Ryan Bowman, Hannah Schwennsen, Kafui Dzirasa, and Rainbo Hultman; 8. Magnetic Resonance Methodologies; Peter A. Bandettini and Hanzhang Lu; 9. PET Brain Imaging Methodologies; Ansel T. Hillmer, Kelly P. Cosgrove, and Richard E. Carson; 10. Neuromodulation and Psychiatric Disorders; Wayne K. Goodman and Mark S. George; 11. The Neurobiology of Sleep; Giulio Tononi and Chiara Cirelli; Section 2: Psychotic Disorders; 12. Diagnosis and Epidemiology of Psychotic Disorders; Emma Meyer, Julie Walsh-Messinger, and Dolores Malaspina; 13. Genetics of Schizophrenia and Bipolar Disorder; Pamela Sklar; 14. Neuroimaging of Psychotic Disorders; Stephan Heckers, Neil Woodward, and Dost Ongur; 15. Animal and Cellular Models of Psychotic Disorders; Mikhail V. Pletnikov, Guo-Li Ming, and Christopher A. Ross; 16. Cognitive and Motivational Neuroscience of Psychotic Disorders: Animal and Human Studies; Jared Young, Alan Anticevic, and Deanna M. Barch; 17. Synaptic Mechanisms of Psychotic Disorders: Animal and Human Studies; Seth G. N. Grant; 18. Cellular Mechanisms of Psychotic Disorders: Human Studies; Samuel J. Dienel and David A. Lewis; 19. Neurodevelopmental Mechanisms for Psychotic Disorders: Animal and Human Studies; Nao J. Gamo, Takeshi Sakurai, Hanna Jaaro-Peled, and Akira Sawa; 20. The Neurobiology and Treatment of Bipolar Disorder; Katherine E. Burdick, Luz H. Ospina, Stephen J. Haggarty, and Roy H. Perlis; 21. Novel Approaches for Treating Psychotic Disorders; Tiago Reis Marques and Shitij Kapur; 22. Current Treatments for Psychotic Disorders; Deepak K. Sarpal and Anil K. Malhotra; Section 3: Depression; 23. Diagnosis and Epidemiology of Depression; Nicholas T. Van Dam, Brian M. Iacoviello, and James W. Murrough; 24. Genetics of Depression; Douglas F. Levinson and Walter E. Nichols; 25. Neuroimaging of Depression; Michele A. Bertocci and Mary L. Phillips; 26. Animal Models of Mood Disorders; Lyonna F. Alcantara, Eric M. Parise, and Carlos A. Bolanos-Guzman; 27. Neurotrophic Mechanisms of Depression: Animal and Human Studies; Ronald S. Duman; 28. Immune Mechanisms of Depression; Caroline Menard, Madeline L. Pfau, Georgia E. Hodes, and Scott J. Russo; 29. Neuroendocrine Mechanisms of Depression: Clinical and Preclinical Evidence; Jill M. Goldstein, L Holsen, S Cherkerzian, M Misra, and RJ Handra; 30. New Approaches for Treating Depression; Eric J. Nestler; 31. Current Treatments for Depression; John H. Krystal and Dennis S. Charney; Section 4: Anxiety Disorders; 32. Diagnosis and Epidemiology of Anxiety, Obsessive-Compulsive and Trauma- and Stressor-Related Disorders; Murray B. Stein, Meghan E. Keough, and Peter P. Roy-Byrne; 33. Genetics of Anxiety Disorders; Takeshi Otowa, Roxann Roberson-Nay, Mandy Bekhbat, Gretchen N. Neigh, and John M. Hettema; 34. Functional Neurocircuitry and Neuroimaging Studies of Anxiety Disorders; Madeleine S. Goodkind and Amit Etkin; 35. Animal Models and Assays Probing anxiety Related Behaviors and Neural Circuits; Ramon Tasan and Nicholas Singewald; 36. Distinct Neural Mechanisms Underlying Fear and Anxiety; Joseph LeDoux; 37. Synaptic and Circuit Mechanisms of Anxiety Disorders: Animal and Human Studies; Anfei Li, Francis S. Lee; 38. The Neurobiology of Resilience; Adriana Feder, Sarah R. Horn, Margaret Haglund, Steven M. Southwick, and Dennis S. Charney; 39. Novel Approaches for Treating Anxiety Disorders; David A. Sturman,Milissa L. Kaufman, Cara E. Bigony, and Kerry J. Ressler; 40. Novel treatment approaches for anxiety disorders; Adam J. Guastella, Alice Norton, Gail A. Alvares, and Christine Song; Section 5: Substance Use Disorders; 41. Epidemiology of Substance Use Disorders; Denise B. Kandel, Mei-Chen Hu, Pamela C. Griesler, Bradley T. Kerridge, and Bridget F. Grant; 42. The Genetic Basis of Addictive Disorders; David Goldman, Zhifeng Zhou, and Colin Hodgkinson; 43. Animal Models of Addiction; Christopher Evans J., Brigitte L. Lieffer, David Jentsch, and Rafael J. Maldonado; 44. Reward Circuitry and Drug Addiction; Vaughn R. Steele, Vani Pariyadath, Rita Z. Goldstein, and Elliot A. Stein; 45. Molecular Neuroimaging in Addictive Disorders; Edythe D. London and Chelsea L. Robertson; 46. Cellular and Molecular Mechanisms of Addiction; Kathryn J. Reissner and Peter W. Kalivas; 47. Brain Development and the Risk for Substance Abuse; Mary M. Heitzeg and B.J. Casey; 48. Pharmacotherapy of Substance Use Disorders; Jane B. Acri and Phil Skolnick; 49. Current Approved Pharmacotherapies for Substance Use Disorders; Alexis S. Hammond and Eric C. Strain; Section 6: Dementia; 50. Diagnosis and Epidemiology of Dementia; William C. Kreisl and Christiane Reitz; 51. Genetics of Dementia; Alan E. Renton and Alison M. Goate; 52. Neuroimaging and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease; Brian A. Gordon, Stephanie J.B. Vos, and Anne M. Fagan; 53. Animal Models of Alzheimer’s Disease; David Morgan; 54. Cellular Mechanisms of Dementia: Animal and Human Studies; Li Gan; 55. Neurobiology of Lewy Body Dementias: Animal and Human Studies; James E. Galvin and Jose Tomas Bras; 56. Neurobiology of FTD: Animal and Human Studies; Dah-eun Chloe Chung, Jeannette N. Stankowski, and Leonard Petrucelli; 57. Current Treatments for Alzheimer’s Disease; Mary Sano and Judith Neugroschil; Section 7: Psychiatric Disorders of Childhood Onset; 58. Diagnosis and Epidemiology of Pediatric Psychiatric Disorders of Childhood; Elise Robinson, Benjamin Neale, and Mark Daly; 59. Genetics of Pediatric Psychiatric Disorders; Silvia de Rubeis, M. Pilar Trelles, and Joseph D. Buxbaum; 60. Neuroimaging in Pediatric Psychiatric Disorder; Timothy P.L. Roberts and Luke Bloy; 61. Animal and Cellular Models of Pediatric Psychiatric Disorders; Elodie Drapeau, Hala Harony-Nicolas, and Jacqueline N. Crawley; 62. Neurodevelopmental Mechanisms of Pediatric Psychiatric Disorders: Animal and Human Studies; Silvia De Rubeis, Kathryn Roeder, and Bernie Devlin; 63. Neurobiology of Autism Spectrum Disorder and Intellectual Disability: Animal and Human Studies; Jesse Costales, Silvia De Rubeis, Jennifer Foss-Feig, Patrick Hof, Joseph D. Buxbaum, and Alexander Kolezvon; 64. Neurobiology of Attention Deficit Hyperactivity Disorder: Animal and Human Studies; Stephen V. Faraone, Pradeep G. Bhide, and Joseph Biederman; 65. The Neurobiology of Tic Disorders and Obsessive-Compulsive Disorder: Human and Animal Studies; Christopher Pittenger; 66. Neurobiology of Eating Disorders: Animal and Human Studies; Thomas Hildebrandt and Ashley Heywood; 67. Novel Approaches for Treating Pediatric Psychiatric Disorders; Supritha Prasad and Edwin H. Cook, Jr.; 68. Current Treatments for Pediatric Psychiatric Disorders; M. Pilar Trelles, Paige Siper, and Dorothy Grice; Section 8: Future of Psychiatric Diagnosis: Toward Precision Psychiatry; 69. DSM-5RG Overview and Goals; Darrel A. Regier, Sarah E. Morris, and Susan K. Schulz; 70. The Present and Future of Psychiatric Diagnosis; Steven E. Hyman; 71. The NIMN Research Domain Criteria Project: Toward Precision Medicine in Psychiatry; Bruce N. Cuthbert; 72. Computational Psychiatry and the Bayesian Brain; Karl J. Friston and Raymond J. Dolan

Trade Policy 买家须知